$HEB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AIM ImmunoTech Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AIM ImmunoTech Inc.. Get notifications about new insider transactions in AIM ImmunoTech Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 25 2021 | HEB | AIM ImmunoTech Inc ... | APPELROUTH STEWART | Director | Buy | P | 2.35 | 10,638 | 24,999 | 92,538 | 81.9 K to 92.5 K (+12.99 %) |
Feb 24 2021 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | CEO & President | Buy | P | 2.26 | 11,062 | 25,000 | 209,630 | 198.6 K to 209.6 K (+5.57 %) |
Dec 17 2020 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | CEO | Buy | P | 1.72 | 14,535 | 25,000 | 198,568 | 184 K to 198.6 K (+7.90 %) |
Dec 11 2020 | HEB | AIM ImmunoTech Inc ... | RODINO III PETER W. | COO, Secretary, Gen ... | Option Exercise | A | 1.85 | 75,000 | 138,750 | 75,000 | |
Dec 11 2020 | HEB | AIM ImmunoTech Inc ... | LINTAL ELLEN M | Chief Financial Off ... | Option Exercise | A | 1.85 | 75,000 | 138,750 | 75,000 | |
Nov 13 2020 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | CEO | Option Exercise | A | 1.96 | 300,000 | 588,000 | 300,000 | |
Sep 03 2020 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | CEO & President | Buy | P | 2.03 | 12,316 | 25,001 | 184,033 | 171.7 K to 184 K (+7.17 %) |
Aug 21 2020 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | CEO | Buy | P | 2.33 | 10,730 | 25,001 | 171,717 | 161 K to 171.7 K (+6.67 %) |
Aug 14 2020 | HEB | AIM ImmunoTech Inc ... | MITCHELL WILLIAM M | Director | Option Exercise | A | 2.77 | 50,000 | 138,500 | 50,000 | |
Aug 14 2020 | HEB | AIM ImmunoTech Inc ... | APPELROUTH STEWART | Director | Option Exercise | A | 2.77 | 50,000 | 138,500 | 50,000 | |
Aug 14 2020 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | CEO | Option Exercise | A | 3.05 | 300,000 | 915,000 | 300,000 | |
Jan 02 2020 | HEB | AIM ImmunoTech Inc ... | LINTAL ELLEN M | CFO | Grant | A | 0.53 | 3,931 | 2,083 | 22,892 | 19 K to 22.9 K (+20.73 %) |
Jan 02 2020 | HEB | AIM ImmunoTech Inc ... | RODINO III PETER W. | Dir Govt Relations/ ... | Grant | A | 0.53 | 6,879 | 3,646 | 58,290 | 51.4 K to 58.3 K (+13.38 %) |
Jan 02 2020 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | Exec.Vice Chairman/ ... | Grant | A | 0.53 | 14,741 | 7,813 | 160,990 | 146.2 K to 161 K (+10.08 %) |
Dec 16 2019 | HEB | AIM ImmunoTech Inc ... | APPELROUTH STEWART | Director | Buy | J | 0.45 | 8,358 | 3,801 | 81,326 | 73 K to 81.3 K (+11.45 %) |
Dec 16 2019 | HEB | AIM ImmunoTech Inc ... | MITCHELL WILLIAM M | Director | Buy | J | 0.45 | 8,358 | 3,801 | 76,407 | 68 K to 76.4 K (+12.28 %) |
Dec 16 2019 | HEB | AIM ImmunoTech Inc ... | LINTAL ELLEN M | CFO | Grant | A | 0.44 | 4,789 | 2,083 | 18,961 | 14.2 K to 19 K (+33.79 %) |
Dec 16 2019 | HEB | AIM ImmunoTech Inc ... | RODINO III PETER W. | Dir Govt Relations/ ... | Grant | A | 0.44 | 8,381 | 3,646 | 51,411 | 43 K to 51.4 K (+19.48 %) |
Dec 16 2019 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | Exec.Vice Chairman/ ... | Grant | A | 0.44 | 17,960 | 7,813 | 146,249 | 128.3 K to 146.2 K (+14.00 %) |
Dec 02 2019 | HEB | AIM ImmunoTech Inc ... | APPELROUTH STEWART | Director | Buy | J | 0.40 | 9,503 | 3,801 | 72,968 | 63.5 K to 73 K (+14.97 %) |
Dec 02 2019 | HEB | AIM ImmunoTech Inc ... | MITCHELL WILLIAM M | Director | Buy | J | 0.40 | 9,503 | 3,801 | 68,049 | 58.5 K to 68 K (+16.23 %) |
Dec 02 2019 | HEB | AIM ImmunoTech Inc ... | LINTAL ELLEN M | CFO | Grant | A | 0.40 | 5,208 | 2,083 | 14,172 | 9 K to 14.2 K (+58.10 %) |
Dec 02 2019 | HEB | AIM ImmunoTech Inc ... | RODINO III PETER W. | Dir Govt Relations/ ... | Grant | A | 0.40 | 9,115 | 3,646 | 43,030 | 33.9 K to 43 K (+26.88 %) |
Dec 02 2019 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | Exec.Vice Chairman/ ... | Grant | A | 0.40 | 19,531 | 7,812 | 128,289 | 108.8 K to 128.3 K (+17.96 %) |
Nov 18 2019 | HEB | AIM ImmunoTech Inc ... | APPELROUTH STEWART | Director | Buy | J | 0.46 | 8,264 | 3,801 | 63,465 | 55.2 K to 63.5 K (+14.97 %) |
Nov 18 2019 | HEB | AIM ImmunoTech Inc ... | MITCHELL WILLIAM M | Director | Buy | J | 0.46 | 8,264 | 3,801 | 58,546 | 50.3 K to 58.5 K (+16.44 %) |
Nov 18 2019 | HEB | AIM ImmunoTech Inc ... | LINTAL ELLEN M | CFO | Grant | A | 0.47 | 4,433 | 2,084 | 8,964 | 4.5 K to 9 K (+97.84 %) |
Nov 18 2019 | HEB | AIM ImmunoTech Inc ... | RODINO III PETER W. | Dir Govt Relations/ ... | Grant | A | 0.47 | 7,752 | 3,643 | 33,915 | 26.2 K to 33.9 K (+29.63 %) |
Nov 18 2019 | HEB | AIM ImmunoTech Inc ... | RODINO III PETER W. | Dir Govt Relations/ ... | Grant | A | 0.47 | 7,752 | 3,643 | 33,915 | 26.2 K to 33.9 K (+29.63 %) |
Nov 18 2019 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | Exec.Vice Chairman/ ... | Grant | A | 0.47 | 16,622 | 7,812 | 108,758 | 92.1 K to 108.8 K (+18.04 %) |
Nov 01 2019 | HEB | AIM ImmunoTech Inc ... | APPELROUTH STEWART | Director | Buy | J | 0.50 | 7,603 | 3,802 | 55,201 | 47.6 K to 55.2 K (+15.97 %) |
Nov 01 2019 | HEB | AIM ImmunoTech Inc ... | MITCHELL WILLIAM M | Director | Buy | J | 0.50 | 7,603 | 3,802 | 50,282 | 42.7 K to 50.3 K (+17.81 %) |
Oct 31 2019 | HEB | AIM ImmunoTech Inc ... | LINTAL ELLEN M | CFO | Grant | A | 0.50 | 4,167 | 2,084 | 4,531 | 364 to 4.5 K (+1,144.78 %) |
Oct 31 2019 | HEB | AIM ImmunoTech Inc ... | RODINO III PETER W. | Dir Govt Relations/ ... | Grant | A | 0.50 | 7,297 | 3,649 | 26,163 | 18.9 K to 26.2 K (+38.68 %) |
Oct 31 2019 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Grant | A | 0.50 | 15,625 | 7,813 | 92,136 | 76.5 K to 92.1 K (+20.42 %) |
Oct 17 2019 | HEB | AIM ImmunoTech Inc ... | MITCHELL WILLIAM M | Director | Buy | J | 0.55 | 6,911 | 3,801 | 42,679 | 35.8 K to 42.7 K (+19.32 %) |
Oct 17 2019 | HEB | AIM ImmunoTech Inc ... | APPELROUTH STEWART | Director | Buy | J | 0.55 | 6,911 | 3,801 | 47,598 | 40.7 K to 47.6 K (+16.99 %) |
Oct 17 2019 | HEB | AIM ImmunoTech Inc ... | RODINO III PETER W. | Dir Govt Relations/ ... | Grant | A | 0.58 | 6,286 | 3,646 | 18,866 | 12.6 K to 18.9 K (+49.97 %) |
Oct 17 2019 | HEB | AIM ImmunoTech Inc ... | RODINO III PETER W. | Dir Govt Relations/ ... | Grant | A | 0.58 | 6,286 | 3,646 | 18,866 | 12.6 K to 18.9 K (+49.97 %) |
Oct 17 2019 | HEB | AIM ImmunoTech Inc ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Grant | A | 0.58 | 13,470 | 7,813 | 76,511 | 63 K to 76.5 K (+21.37 %) |
Oct 04 2019 | HEB | AIM ImmunoTech Inc ... | APPELROUTH STEWART | Director | Buy | J | 0.76 | 5,002 | 3,802 | 40,687 | 35.7 K to 40.7 K (+14.02 %) |
Oct 04 2019 | HEB | AIM ImmunoTech Inc ... | APPELROUTH STEWART | Director | Buy | J | 0.76 | 5,002 | 3,802 | 40,687 | 35.7 K to 40.7 K (+14.02 %) |
Oct 04 2019 | HEB | AIM ImmunoTech Inc ... | MITCHELL WILLIAM M | Director | Buy | J | 0.76 | 5,002 | 3,802 | 35,768 | 30.8 K to 35.8 K (+16.26 %) |
Sep 18 2019 | HEB | AIM ImmunoTech Inc ... | APPELROUTH STEWART | Director | Buy | J | 1.87 | 2,033 | 3,802 | 35,685 | 33.7 K to 35.7 K (+6.04 %) |
Sep 18 2019 | HEB | AIM ImmunoTech Inc ... | MITCHELL WILLIAM M | Director | Buy | J | 1.87 | 2,033 | 3,802 | 30,766 | 28.7 K to 30.8 K (+7.08 %) |
Sep 05 2019 | HEB | AIM ImmunoTech Inc ... | APPELROUTH STEWART | Director | Buy | J | 1.80 | 2,112 | 3,802 | 33,652 | 31.5 K to 33.7 K (+6.70 %) |
Sep 05 2019 | HEB | AIM ImmunoTech Inc ... | MITCHELL WILLIAM M | Director | Buy | J | 1.80 | 2,112 | 3,802 | 28,733 | 26.6 K to 28.7 K (+7.93 %) |
Aug 20 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | J | 1.90 | 2,001 | 3,802 | 31,540 | 29.5 K to 31.5 K (+6.77 %) |
Aug 20 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | J | 1.90 | 2,001 | 3,802 | 26,621 | 24.6 K to 26.6 K (+8.13 %) |
Aug 02 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | J | 2.35 | 1,618 | 3,802 | 24,620 | 23 K to 24.6 K (+7.03 %) |
Aug 02 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | J | 2.35 | 1,618 | 3,802 | 29,539 | 27.9 K to 29.5 K (+5.79 %) |
Jul 18 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | J | 4.13 | 920 | 3,800 | 28,494 | 27.6 K to 28.5 K (+3.34 %) |
Jul 18 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | J | 4.13 | 920 | 3,800 | 22,624 | 21.7 K to 22.6 K (+4.24 %) |
Jul 08 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | J | 4.39 | 866 | 3,802 | 27,574 | 26.7 K to 27.6 K (+3.24 %) |
Jul 08 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | J | 4.39 | 866 | 3,802 | 21,704 | 20.8 K to 21.7 K (+4.16 %) |
Jun 27 2019 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 4.37 | 2,632 | 11,502 | 63,041 | 60.4 K to 63 K (+4.36 %) |
Jun 25 2019 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Buy | P | 4.03 | 2,481 | 9,998 | 5,420 | 2.9 K to 5.4 K (+84.42 %) |
Jun 25 2019 | HEB | HEMISPHERX BIOPHAR ... | RODINO III PETER W. | Dir Govt Relations/ ... | Buy | P | 4.03 | 8,695 | 35,041 | 12,590 | 3.9 K to 12.6 K (+223.23 %) |
Jun 25 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | P | 4.03 | 9,677 | 38,998 | 26,708 | 17 K to 26.7 K (+56.82 %) |
Jun 24 2019 | HEB | HEMISPHERX BIOPHAR ... | SPRINGATE WAYNE S | Sr. VP of Operation ... | Buy | P | 4.03 | 5,211 | 21,000 | 8,672 | 3.5 K to 8.7 K (+150.56 %) |
Jun 24 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | P | 4.03 | 9,677 | 38,998 | 20,838 | 11.2 K to 20.8 K (+86.70 %) |
Jun 21 2019 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 4.03 | 29,404 | 118,498 | 1,393,611 | 1.4 M to 1.4 M (+2.16 %) |
Jun 18 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | J | 5.35 | 711 | 3,804 | 17,031 | 16.3 K to 17 K (+4.36 %) |
Jun 18 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | J | 5.35 | 711 | 3,804 | 11,161 | 10.5 K to 11.2 K (+6.80 %) |
Jun 18 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | C | 0.00 | 140,000 | 0 | 459,805 | 319.8 K to 459.8 K (+43.78 %) |
Jun 18 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | C | 0.00 | 200,000 | 0 | 319,805 | 119.8 K to 319.8 K (+166.94 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | C | 0.00 | 200,000 | 0 | 718,096 | 518.1 K to 718.1 K (+38.60 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | C | 0.00 | 140,000 | 0 | 518,096 | 378.1 K to 518.1 K (+37.03 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | C | 0.00 | 200,000 | 0 | 718,096 | 518.1 K to 718.1 K (+38.60 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | C | 0.00 | 140,000 | 0 | 518,096 | 378.1 K to 518.1 K (+37.03 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | SPRINGATE WAYNE S | Sr. VP of Operation ... | Buy | C | 0.00 | 35,000 | 0 | 152,273 | 117.3 K to 152.3 K (+29.84 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | SPRINGATE WAYNE S | Sr. VP of Operation ... | Buy | C | 0.00 | 50,000 | 0 | 117,273 | 67.3 K to 117.3 K (+74.32 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | RODINO III PETER W. | Dir Govt Relations/ ... | Buy | C | 0.00 | 63,000 | 0 | 171,373 | 108.4 K to 171.4 K (+58.13 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | RODINO III PETER W. | Dir Govt Relations/ ... | Buy | C | 0.00 | 90,000 | 0 | 108,373 | 18.4 K to 108.4 K (+489.85 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Buy | C | 0.00 | 35,000 | 0 | 129,304 | 94.3 K to 129.3 K (+37.11 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Buy | C | 0.00 | 50,000 | 0 | 94,304 | 44.3 K to 94.3 K (+112.86 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | C | 0.00 | 227,500 | 0 | 1,364,207 | 1.1 M to 1.4 M (+20.01 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | C | 0.00 | 325,000 | 0 | 1,136,707 | 811.7 K to 1.1 M (+40.04 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Buy | C | 0.00 | 35,000 | 0 | 147,148 | 112.1 K to 147.1 K (+31.21 %) |
Jun 17 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Buy | C | 0.00 | 50,000 | 0 | 112,148 | 62.1 K to 112.1 K (+80.45 %) |
Jun 14 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | J | 0.10 | 38,013 | 3,801 | 119,805 | 81.8 K to 119.8 K (+46.48 %) |
Jun 14 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | J | 0.15 | 25,342 | 3,801 | 81,792 | 56.5 K to 81.8 K (+44.89 %) |
Jun 14 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | J | 0.21 | 18,101 | 3,801 | 56,450 | 38.3 K to 56.5 K (+47.20 %) |
Jun 14 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | J | 0.14 | 27,152 | 3,801 | 38,349 | 11.2 K to 38.3 K (+242.49 %) |
Jun 14 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | J | 0.10 | 38,013 | 3,801 | 378,096 | 340.1 K to 378.1 K (+11.18 %) |
Jun 14 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | J | 0.15 | 25,342 | 3,801 | 340,083 | 314.7 K to 340.1 K (+8.05 %) |
Jun 14 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | J | 0.21 | 18,101 | 3,801 | 314,741 | 296.6 K to 314.7 K (+6.10 %) |
Jun 14 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | J | 0.14 | 27,152 | 3,801 | 296,640 | 269.5 K to 296.6 K (+10.08 %) |
Mar 19 2019 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 0.18 | 13,400 | 2,352 | 811,707 | 798.3 K to 811.7 K (+1.68 %) |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | X | 1,000.00 | 40 | 40,000 | 0 | |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | X | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Buy | X | 0.00 | 40 | 0 | 40 | 0 to 40 |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Option Exercise | X | 1,000.00 | 40 | 40,000 | 0 | |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | X | 0.00 | 200,000 | 0 | 200,000 | 0 to 200 K |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | X | 0.00 | 40 | 0 | 40 | 0 to 40 |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | SPRINGATE WAYNE S | Sr. VP of Operation ... | Option Exercise | X | 1,000.00 | 10 | 10,000 | 0 | |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | SPRINGATE WAYNE S | Sr. VP of Operation ... | Buy | X | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | SPRINGATE WAYNE S | Sr. VP of Operation ... | Buy | X | 0.00 | 10 | 0 | 10 | 0 to 10 |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Option Exercise | X | 1,000.00 | 10 | 10,000 | 0 | |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Buy | X | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Buy | X | 0.00 | 10 | 0 | 10 | 0 to 10 |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | RODINO III PETER W. | Dir Govt Relations/ ... | Option Exercise | X | 1,000.00 | 18 | 18,000 | 0 | |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | RODINO III PETER W. | Dir Govt Relations/ ... | Buy | X | 0.00 | 90,000 | 0 | 90,000 | 0 to 90 K |
Mar 13 2019 | HEB | HEMISPHERX BIOPHAR ... | RODINO III PETER W. | Dir Govt Relations/ ... | Buy | X | 0.00 | 18 | 0 | 18 | 0 to 18 |
Mar 12 2019 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Option Exercise | X | 1,000.00 | 65 | 65,000 | 0 | |
Mar 12 2019 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | X | 0.00 | 325,000 | 0 | 325,000 | 0 to 325 K |
Mar 12 2019 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | X | 0.00 | 65 | 0 | 65 | 0 to 65 |
Mar 12 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Option Exercise | X | 1,000.00 | 10 | 10,000 | 0 | |
Mar 12 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Buy | X | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Mar 12 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Buy | X | 0.00 | 10 | 0 | 10 | 0 to 10 |
Jan 30 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Option Exercise | A | 0.22 | 50,000 | 11,000 | 50,000 | |
Jan 30 2019 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Option Exercise | A | 0.22 | 207,343 | 45,615 | 207,343 | |
Jan 30 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | A | 0.22 | 50,000 | 11,000 | 50,000 | |
Jan 30 2019 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | A | 0.22 | 207,343 | 45,615 | 207,343 | |
Jan 30 2019 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Option Exercise | A | 0.22 | 184,659 | 40,625 | 184,659 | |
Jan 30 2019 | HEB | HEMISPHERX BIOPHAR ... | RODINO III PETER W. | Dir Govt Relations/ ... | Option Exercise | A | 0.22 | 198,864 | 43,750 | 198,864 | |
Jan 30 2019 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Option Exercise | A | 0.22 | 142,046 | 31,250 | 142,046 | |
Jan 30 2019 | HEB | HEMISPHERX BIOPHAR ... | SPRINGATE WAYNE S | Sr. VP of Operation ... | Option Exercise | A | 0.22 | 142,046 | 31,250 | 142,046 | |
Jan 30 2019 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Option Exercise | A | 0.22 | 426,136 | 93,750 | 426,136 | |
Dec 03 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 0.20 | 6,000 | 1,176 | 798,307 | 792.3 K to 798.3 K (+0.76 %) |
Dec 03 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 0.19 | 334 | 65 | 792,307 | 792 K to 792.3 K (+0.04 %) |
Dec 03 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 0.19 | 300 | 58 | 791,973 | 791.7 K to 792 K (+0.04 %) |
Dec 03 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 0.19 | 50 | 10 | 791,673 | 791.6 K to 791.7 K (+0.01 %) |
Dec 03 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 0.19 | 2,400 | 463 | 791,623 | 789.2 K to 791.6 K (+0.30 %) |
Dec 03 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 0.19 | 9,557 | 1,816 | 789,223 | 779.7 K to 789.2 K (+1.23 %) |
Dec 03 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 0.19 | 5 | 1 | 779,666 | 779.7 K to 779.7 K (0.00 %) |
Dec 03 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 0.19 | 1,354 | 256 | 779,661 | 778.3 K to 779.7 K (+0.17 %) |
Nov 29 2018 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Grant | A | 0.00 | 2,500 | 0 | 11,197 | 8.7 K to 11.2 K (+28.75 %) |
Nov 29 2018 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Grant | A | 0.00 | 2,500 | 0 | 269,488 | 267 K to 269.5 K (+0.94 %) |
Nov 29 2018 | HEB | HEMISPHERX BIOPHAR ... | RODINO III PETER W. | Dir Govt Relations/ ... | Grant | A | 0.00 | 2,500 | 0 | 18,373 | 15.9 K to 18.4 K (+15.75 %) |
Nov 29 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Grant | A | 0.00 | 2,500 | 0 | 778,307 | 775.8 K to 778.3 K (+0.32 %) |
Nov 29 2018 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Grant | A | 0.00 | 2,500 | 0 | 44,304 | 41.8 K to 44.3 K (+5.98 %) |
Nov 29 2018 | HEB | HEMISPHERX BIOPHAR ... | SPRINGATE WAYNE S | Sr. VP of Operation ... | Grant | A | 0.00 | 2,500 | 0 | 67,273 | 64.8 K to 67.3 K (+3.86 %) |
Nov 29 2018 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Grant | A | 0.00 | 2,500 | 0 | 62,148 | 59.6 K to 62.1 K (+4.19 %) |
Nov 16 2018 | HEB | HEMISPHERX BIOPHAR ... | RODINO III PETER W. | Dir Govt Relations/ ... | Option Exercise | A | 0.22 | 1,000 | 220 | 1,000 | |
Nov 16 2018 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Option Exercise | A | 0.22 | 1,000 | 220 | 1,000 | |
Nov 16 2018 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Option Exercise | A | 0.22 | 1,000 | 220 | 1,000 | |
Nov 16 2018 | HEB | HEMISPHERX BIOPHAR ... | SPRINGATE WAYNE S | Sr. VP of Operation ... | Option Exercise | A | 0.22 | 1,000 | 220 | 1,000 | |
Nov 16 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Option Exercise | A | 0.22 | 1,000 | 220 | 1,000 | |
Nov 16 2018 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Option Exercise | A | 0.22 | 1,000 | 220 | 1,000 | |
Nov 06 2018 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Buy | P | 0.22 | 25,238 | 5,552 | 266,988 | 241.8 K to 267 K (+10.44 %) |
Oct 29 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 0.20 | 3,500 | 711 | 775,807 | 772.3 K to 775.8 K (+0.45 %) |
Oct 25 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Buy | P | 0.20 | 100,000 | 20,000 | 772,307 | 672.3 K to 772.3 K (+14.87 %) |
Oct 19 2018 | HEB | HEMISPHERX BIOPHAR ... | APPELROUTH STEWART | Director | Option Exercise | A | 0.22 | 172,786 | 38,013 | 172,786 | |
Oct 19 2018 | HEB | HEMISPHERX BIOPHAR ... | MITCHELL WILLIAM M | Director | Option Exercise | A | 0.22 | 172,786 | 38,013 | 172,786 | |
Oct 19 2018 | HEB | HEMISPHERX BIOPHAR ... | RODINO III PETER W. | Dir Govt Relations/ ... | Option Exercise | A | 0.22 | 132,576 | 29,167 | 132,576 | |
Oct 19 2018 | HEB | HEMISPHERX BIOPHAR ... | EQUELS THOMAS K. | Exec. Vice Chairman ... | Option Exercise | A | 0.22 | 284,091 | 62,500 | 284,091 | |
Oct 19 2018 | HEB | HEMISPHERX BIOPHAR ... | SPRINGATE WAYNE S | Sr. VP of Operation ... | Option Exercise | A | 0.22 | 94,697 | 20,833 | 94,697 | |
Oct 19 2018 | HEB | HEMISPHERX BIOPHAR ... | STRAYER DAVID R | Chief Science/Medic ... | Option Exercise | A | 0.22 | 123,106 | 27,083 | 123,106 | |
Oct 19 2018 | HEB | HEMISPHERX BIOPHAR ... | PASCALE ADAM | CFO | Option Exercise | A | 0.22 | 94,697 | 20,833 | 94,697 |